The global immunoassay market is poised for substantial expansion, projected to reach USD 45.78 billion by 2032, up from USD 29.51 billion in 2022, growing at a steady CAGR of 5%. This growth is ...

The stock prices of pharmaceutical firms increased on 11 April after US President Trump suspended his reciprocal tariffs for ...